Cargando…
The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer
Prostate cancer antigen 3 (PCA3) is an overexpressed prostate long non-coding RNA (lncRNA), transcribed from an intronic region at the long arm of human chromosome 9q21–22. It has been described that PCA3 modulates prostate cancer (PCa) cell survival through modulating androgen receptor (AR) signali...
Autores principales: | Lemos, Ana Emília Goulart, Matos, Aline da Rocha, Ferreira, Luciana Bueno, Gimba, Etel Rodrigues Pereira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859920/ https://www.ncbi.nlm.nih.gov/pubmed/31762940 http://dx.doi.org/10.18632/oncotarget.27284 |
Ejemplares similares
-
Susceptibility of lung cancer patients to COVID‐19: A review of the pandemic data from multiple nationalities
por: Lemos, Ana Emília Goulart, et al.
Publicado: (2021) -
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
por: Ferreira, Luciana Bueno, et al.
Publicado: (2012) -
Osteopontin-c mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor signaling
por: TILLI, TATIANA MARTINS, et al.
Publicado: (2015) -
Osteopontin Expression in Thyroid Cancer: Deciphering EMT-Related Molecular Mechanisms
por: Viana, Bruna Prunes Pena Baroni, et al.
Publicado: (2021) -
Molecular Aspects of Thyroid Calcification
por: Ferreira, Luciana Bueno, et al.
Publicado: (2020)